Literature DB >> 25528219

Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity.

Alvise Berti1, Corrado Campochiaro2, Giulio Cavalli2, Gino Pepe3, Luisa Praderio4, Maria Grazia Sabbadini2, Lorenzo Dagna2.   

Abstract

OBJECTIVE: Giant cell arteritis (GCA) is a systemic vasculitis typically affecting temporal arteries. In at least 15% of cases, GCA also features inflammation of the aorta and its primary branches. Large-vessel inflammation restricted to proximal limb arteries in the absence of temporal and aortic involvement (Limb Restricted, LR) is rare and not well described in literature. Hence, we aim to characterize this neglected clinical entity.
METHODS: We describe a series of three cases of LR-GCA. All patients were older than 50 years, had increased erythrocyte sedimentation rate (ESR), normal cholesterol and triglycerides serum levels, negative temporal artery biopsy, suggestive F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) findings, and responded to immunosuppressive therapy. We also reviewed all published cases of LR-GCA (76 cases), for a total of 79 patients.
RESULTS: Limb claudication was reported in 87% of the patients, and cranial symptoms and polymyalgia rheumatica in 20%. Constitutional symptoms were never reported. Median ESR levels were 66.5mm/1h. Upper and lower limb arteries were involved in 86% and 9% of the patients respectively, and the remaining 5% had simultaneous upper and lower limb vessel involvement. Conventional angiography was performed in 63% of the cases, color-doppler ultrasound in 20%, FDG-PET in 14%, and computed tomography angiography in 3%.
CONCLUSION: If temporal biopsy and aortic imaging are negative for GCA in patients older than 50 years with bilateral limb claudication, elevated ESR, and suggestive vascular radiological findings, LR-GCA should be suspected. Upper limb arteries are more frequently involved. Since constitutional symptoms are typically absent in LR-GCA, differential diagnosis with atherosclerotic plaques may be challenging.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brachial GCA; Claudication FDG-PET; Extracranial GCA; Large-vessel GCA; Limb-restricted GCA

Mesh:

Year:  2014        PMID: 25528219     DOI: 10.1016/j.autrev.2014.12.005

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  11 in total

Review 1.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 2.  Giant cell arteritis: ophthalmic manifestations of a systemic disease.

Authors:  Elisabeth De Smit; Eoin O'Sullivan; David A Mackey; Alex W Hewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-05       Impact factor: 3.117

Review 3.  Imaging in Giant Cell Arteritis.

Authors:  Asad Khan; Bhaskar Dasgupta
Journal:  Curr Rheumatol Rep       Date:  2015-08       Impact factor: 4.592

Review 4.  An Updated Review of Cardiovascular Events in Giant Cell Arteritis.

Authors:  Hubert de Boysson; Achille Aouba
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

Review 5.  New Insights into the Pathogenesis of Giant Cell Arteritis: Mechanisms Involved in Maintaining Vascular Inflammation.

Authors:  Hélène Greigert; Coraline Genet; André Ramon; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

Review 6.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 7.  Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic.

Authors:  Giulio Cavalli; Nicola Farina; Corrado Campochiaro; Giacomo De Luca; Emanuel Della-Torre; Alessandro Tomelleri; Lorenzo Dagna
Journal:  Front Pharmacol       Date:  2020-12-18       Impact factor: 5.988

8.  Critical arm ischemia-a rare presentation of giant cell arteritis.

Authors:  Ali Hage; Carman Iannicello
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-03-23

Review 9.  Anakinra Therapy for Non-cancer Inflammatory Diseases.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

10.  Giant cell arteritis as unusual cause of critical arm ischemia.

Authors:  Thomas Ratschiller; Hannes Müller; Markus Pirklbauer; Rene Silye; Gregor Sulzbacher; Andreas Zierer
Journal:  J Vasc Surg Cases Innov Tech       Date:  2018-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.